CNY 25.67
(-0.62%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 24.13 Billion CNY | 14.72% |
2022 | 21.03 Billion CNY | 23.38% |
2021 | 17.05 Billion CNY | 31.68% |
2020 | 12.94 Billion CNY | 41.14% |
2019 | 9.17 Billion CNY | 16.61% |
2018 | 7.86 Billion CNY | 64.52% |
2017 | 4.78 Billion CNY | 13.3% |
2016 | 4.22 Billion CNY | 73.24% |
2015 | 2.43 Billion CNY | 94.79% |
2014 | 1.25 Billion CNY | 21.88% |
2013 | 1.02 Billion CNY | 21.4% |
2012 | 845.44 Million CNY | 0.24% |
2011 | 843.4 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 27.21 Billion CNY | 2.93% |
2024 Q1 | 26.16 Billion CNY | 8.39% |
2024 Q2 | 26.43 Billion CNY | 1.05% |
2023 Q3 | 21.93 Billion CNY | 4.01% |
2023 Q4 | 24.13 Billion CNY | 10.04% |
2023 FY | 24.13 Billion CNY | 14.72% |
2023 Q1 | 21.39 Billion CNY | 1.71% |
2023 Q2 | 21.08 Billion CNY | -1.45% |
2022 Q4 | 21.03 Billion CNY | 10.42% |
2022 Q3 | 19.05 Billion CNY | 6.77% |
2022 Q1 | 17.3 Billion CNY | 1.46% |
2022 Q2 | 17.84 Billion CNY | 3.15% |
2022 FY | 21.03 Billion CNY | 23.38% |
2021 Q1 | 15.75 Billion CNY | 21.7% |
2021 Q4 | 17.05 Billion CNY | 8.85% |
2021 Q3 | 15.66 Billion CNY | -0.92% |
2021 FY | 17.05 Billion CNY | 31.68% |
2021 Q2 | 15.81 Billion CNY | 0.33% |
2020 Q1 | 9.8 Billion CNY | 6.82% |
2020 FY | 12.94 Billion CNY | 41.14% |
2020 Q3 | 11.84 Billion CNY | 4.24% |
2020 Q4 | 12.94 Billion CNY | 9.3% |
2020 Q2 | 11.36 Billion CNY | 15.97% |
2019 FY | 9.17 Billion CNY | 16.61% |
2019 Q4 | 9.17 Billion CNY | 10.71% |
2019 Q3 | 8.28 Billion CNY | 2.32% |
2019 Q2 | 8.09 Billion CNY | 0.66% |
2019 Q1 | 8.04 Billion CNY | 2.26% |
2018 Q2 | 5.02 Billion CNY | -1.52% |
2018 Q4 | 7.86 Billion CNY | 19.86% |
2018 Q3 | 6.56 Billion CNY | 30.51% |
2018 Q1 | 5.1 Billion CNY | 6.79% |
2018 FY | 7.86 Billion CNY | 64.52% |
2017 Q1 | 4.24 Billion CNY | 0.46% |
2017 FY | 4.78 Billion CNY | 13.3% |
2017 Q4 | 4.78 Billion CNY | 5.73% |
2017 Q3 | 4.52 Billion CNY | 7.54% |
2017 Q2 | 4.2 Billion CNY | -0.81% |
2016 Q3 | 4.1 Billion CNY | 54.31% |
2016 Q2 | 2.66 Billion CNY | 8.05% |
2016 Q1 | 2.46 Billion CNY | 1.07% |
2016 FY | 4.22 Billion CNY | 73.24% |
2016 Q4 | 4.22 Billion CNY | 2.8% |
2015 Q1 | 2.1 Billion CNY | 68.49% |
2015 Q4 | 2.43 Billion CNY | 5.12% |
2015 Q3 | 2.31 Billion CNY | 10.0% |
2015 Q2 | 2.1 Billion CNY | -0.03% |
2015 FY | 2.43 Billion CNY | 94.79% |
2014 Q1 | - CNY | 0.0% |
2014 FY | 1.25 Billion CNY | 21.88% |
2014 Q2 | 1.04 Billion CNY | 0.0% |
2014 Q4 | 1.25 Billion CNY | 0.0% |
2013 FY | 1.02 Billion CNY | 21.4% |
2012 FY | 845.44 Million CNY | 0.24% |
2011 FY | 843.4 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Shanghai No.1 Pharmacy Co., Ltd. | 1.86 Billion CNY | -1195.456% |
Jointown Pharmaceutical Group Co., Ltd | 92.78 Billion CNY | 73.988% |
LBX Pharmacy Chain Joint Stock Company | 22.2 Billion CNY | -8.722% |
Yunnan Jianzhijia Health-Chain Co., Ltd. | 9.94 Billion CNY | -142.604% |